The wrist-worn devices may identify patients who would benefit from stroke prevention therapies.
Explore This Procedure
The Arrhythmia Genetics Clinic at the Massachusetts General Hospital Corrigan Minehan Heart Center provides specialized care for individuals with suspected or diagnosed genetic conditions that may increase the risk of a heart rhythm disturbance, known as an arrhythmia.
Multidisciplinary Care at the Arrhythmia Genetics Clinic
Conditions We Treat: Comprehensive Care
Many altered electrical or structural changes in the heart are caused by genetic factors. Our multidisciplinary team provides care that includes a comprehensive cardiovascular evaluation and counseling to diagnose conditions that increase the risk of cardiac arrhythmias. Our team includes cardiologists and nurses who specialize in cardiac arrhythmias and who have expertise in the use and interpretation of genetic information. We utilize a number of diagnostic, risk stratification and therapeutic tools to help direct treatment, and we work closely with colleagues specializing in cardiovascular imaging and other cardiovascular specialists. We specialize in treating conditions such as:
- Brugada syndrome
- Long QT syndrome
- Short QT syndrome
- Arrhythmogenic cardiomyopathy / arrhythmogenic right ventricular cardiomyopathy
- Catecholaminergic polymorphic ventricular tachycardia
- Early onset atrial fibrillation
- Early repolarization syndrome
- Unexplained sudden cardiac arrest
- Idiopathic ventricular tachycardia or ventricular fibrillation
Our experts in the Corrigan Minehan Heart Center are skilled both in invasive and noninvasive therapies that may be necessary for patients with inherited arrhythmia conditions. These treatments include genetic testing, pharmacologic management, implantation of cardiac pacemakers or defibrillators, catheter ablation, cardiac surgery or other options.
Diagnosis: What to Expect
Your evaluation will typically include a detailed medical history, family history and physical examination, as well as education and counseling.
At the conclusion of your visit, we may recommend other tests to help diagnose or evaluate your potential condition.
We request that you provide a list of your immediate and extended family members, along with their ages and their medical histories (patients may use a tool such as My Family Health Portrait). If you have had a prior evaluation, please bring with you any relevant data that you have.
Genetic Testing and Family Screening
We frequently recommend clinical genetic testing to facilitate diagnosis, help direct care or to enable efficient screening of family members at risk. Typically, genetic testing involves collection of a blood sample.
Since genetic conditions are usually inherited, our providers consider the familial implications of being diagnosed with a genetic arrhythmia syndrome. Our clinicians can conduct an evaluation of family members to provide counseling and determine if they are at risk for the particular arrhythmia syndrome
Treatments & Procedures: Experienced Physicians and Genetics Expertise
The Arrhythmia Genetics Clinic at the Massachusetts General Hospital Corrigan Minehan Heart Center is led by Steven Lubitz, MD, MPH; Patrick Ellinor, MD, PhD and David Milan, MD. The clinic is structured to provide patients with comprehensive, expert care, and through ongoing research, is focused on establishing new best practices for the treatment of genetic arrhythmias.
Our comprehensive care includes:
- Genetic testing
- Risk stratification and diagnostics
- Invasive electrophysiology diagnostic testing
- Medical treatments
- Pacemakers and defibrillators
We are committed to understanding the causes and management of genetic cardiac arrhythmias. Our clinicians conduct leading-edge research to determine the mechanisms of these conditions and identify ways to treat these arrhythmias. During your visit with us, please ask about our ongoing research protocols to learn more.
Related News and Articles
- Patient Education
- May | 24 | 2022
On May 24, 2022, the Massachusetts General Hospital Transplant Center held a virtual, fireside chat to share the latest updates on COVID-19 and transplantation.
- Press Release
- Apr | 18 | 2022
Women who had experienced infertility had a 16% increased risk of heart failure compared with women who did not have an infertility history.
- Press Release
- Mar | 3 | 2022
Handheld devices for A-fib screening may be most effective in the oldest adults during primary care visits
Advanced consumer technology has produced small electrocardiogram devices that could be efficiently deployed in point-of-care screening for atrial fibrillation, though the proportion of cases detected among all patients 65 and older is small.
- Press Release
- Mar | 2 | 2022
Mutations in genes that direct the production of fibrillar collagens, essential components of blood vessel walls, appear to predispose individuals to SCAD.
- Feb | 14 | 2022
Heart disease is the leading cause of death in men and women alike. In this presentation, Dr. Emily Lau reviews the epidemiology of heart disease in women, differences in heart disease between women and men, and special considerations for promoting female heart health.